↓ Skip to main content

Multi-targeted kinase inhibition alleviates mTOR inhibitor resistance in triple-negative breast cancer

Overview of attention for article published in Breast Cancer Research and Treatment, August 2019
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (69th percentile)
  • Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

twitter
5 X users
patent
1 patent

Citations

dimensions_citation
27 Dimensions

Readers on

mendeley
152 Mendeley
Title
Multi-targeted kinase inhibition alleviates mTOR inhibitor resistance in triple-negative breast cancer
Published in
Breast Cancer Research and Treatment, August 2019
DOI 10.1007/s10549-019-05380-z
Pubmed ID
Authors

Jichao He, Ronan P. McLaughlin, Vera van der Noord, John A. Foekens, John W. M. Martens, Gerard van Westen, Yinghui Zhang, Bob van de Water

X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 152 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 152 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 38 25%
Student > Ph. D. Student 6 4%
Student > Master 5 3%
Researcher 3 2%
Student > Postgraduate 2 1%
Other 4 3%
Unknown 94 62%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 29 19%
Biochemistry, Genetics and Molecular Biology 20 13%
Medicine and Dentistry 3 2%
Agricultural and Biological Sciences 2 1%
Immunology and Microbiology 1 <1%
Other 0 0%
Unknown 97 64%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 September 2021.
All research outputs
#5,991,967
of 23,153,849 outputs
Outputs from Breast Cancer Research and Treatment
#1,314
of 4,692 outputs
Outputs of similar age
#105,979
of 345,067 outputs
Outputs of similar age from Breast Cancer Research and Treatment
#18
of 74 outputs
Altmetric has tracked 23,153,849 research outputs across all sources so far. This one has received more attention than most of these and is in the 73rd percentile.
So far Altmetric has tracked 4,692 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.2. This one has gotten more attention than average, scoring higher than 71% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 345,067 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 69% of its contemporaries.
We're also able to compare this research output to 74 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 75% of its contemporaries.